Artificial Intelligence Ventus Therapeutics | Developing Small Molecule Medicines


Enterprise, Biotechnology, Pharmaceuticals, Life Science, Drug Discovery, Immunology Montreal, QC, Canada

Ventus Therapeutics

Artificial Intelligence


Ventus Therapeutics | Developing Small Molecule Medicines

Ventus Therapeutics

Biotechnology, Pharmaceuticals, Life Science, Drug Discovery, Immunology


Montreal, QC, Canada

At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but elusive, drug targets.  Using two platforms, we expand the set of targets amenable to small-molecule medicines including targets that have never been drugged and others for which existing chemical matter leaves significant room for improvement.

Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Our structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system. Advancing the next frontier for structure-based drug design to navigate elusive targets, in Montreal and Waltham, MA.

 
 

   Total Funding: $160 M

   Funding Stage: Series B

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 26 to 50

   Founded: 2019

 
 

Date

Round

$ Raised

Investors

04/08/2021

Series B

$100M

Biotechnology Value Fund, Casdin Capital, Cormorant Asset Management, Fonds de solidarite FTQ, GV, RA Capital Management, Versant Ventures

Date : 04/08/2021

Round: Series B

$ Raised: $100M

Investors: Biotechnology Value Fund, Casdin Capital, Cormorant Asset Management, Fonds de solidarite FTQ, GV, RA Capital Management, Versant Ventures

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Ventus Therapeutics

 
 
 
Marcelo Bigal


Marcelo Bigal
President and CEO

Dan Koerwer


Dan Koerwer
Chief Business Officer

Zack McNealy


Zack McNealy
CFO

Michael Crackower


Michael Crackower
Chief Scientific Officer

 
 

Ventus Therapeutics is growing. Want to work at Ventus Therapeutics? Ventus Therapeutics is hiring. Join team at Ventus Therapeutics

 

View All

Executive Director, Head of Medicinal Chemistry

Waltham, Massachusetts

Executive Director, Head of Medicinal Chemistry

Montreal, Quebec

Director of Human Resources

Montreal, Quebec

 
 
appengine.ai

World's Most Promising AI/ML Startups